The blockbuster agreement between Sumitomo Dainippon Pharma and BehaVR is likely one of the largest ever struck for VR therapeutics Quick read ➨ Sumitomo Dainippon…
Latest News
- Niantic continues AR acquisition spree with NZXR deal
- TRW: Feature-rich Arkio comes to Meta Quest 2
- VR streaming platform LIV raises $8.5m, plans creator and developer investment
- Mojo Vision unveils advanced AR contact lens prototype
- Nreal raises another $60m of funding
- Osso VR raises $66m and plans hiring spree
- Autodesk seals deal for The Wild to begin its XR journey
- Nike claims almost seven million people have visited Roblox micro metaverse
- NFL and StatusPRO planning official VR game for Meta Quest and PlayStation…
- Tobii, LIV and Ready Player Me bring eye tracking to the Metaverse
